Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:30 PM
Ignite Modification Date:
2025-12-24 @ 9:30 PM
NCT ID:
NCT05445232
Eligibility Criteria:
Inclusion Criteria:
* Body mass index (BMI) within the range 27.0 to 40.0 kilograms per meter squared (kg/m²)
* Male and female participants of childbearing potential who agree to use contraceptive methods
Exclusion Criteria:
* Have a history of diabetes or current diagnosis of diabetes
* History or presence of a of significant bleeding disorder
* Participants with significant comorbidity
* Participants receiving treatment with midazolam, warfarin, inhibitors or inducers of cytochrome P450 (CYP) -1A2, CYP2C9, or CYP3A4 enzymes, or drugs are CYP substrates and have a narrow therapeutic index
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT05445232
Study Brief:
Protocol Section:
NCT05445232